TREA

79081065 - ECTYCELL

Follow

Information

  • Trademark
  • 79081065
  • Serial Number
    79081065
  • Registration Number
    3939980
  • Filing Date
    October 02, 2009
    16 years ago
  • Registration Date
    April 05, 2011
    14 years ago
  • Transaction Date
    April 18, 2020
    5 years ago
  • Status Date
    October 03, 2019
    6 years ago
  • Published for Opposition Date
    January 18, 2011
    14 years ago
  • Location Date
    April 05, 2011
    14 years ago
  • Status Code
    404
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    CLAYTON, CHERYL A
  • Attorney Docket Number
    1169-060TM
    Attorney Name
    Jeffrey H. Greger
    Law Office Assigned Location Code
    L20
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
ECTYCELL
Case File Statements
  • GS0011: Chemical, biochemical, biotechnological and bacteriological products for use in industry, science, agriculture, horticulture, namely, chemicals used for industrial purposes, polypeptides for in vivo and in vitro genetic engineering, nucleic acid vectors, natural and engineered meganucleases and endonucleases; chemical, biochemical, biotechnological and bacteriological products for use in research and testing laboratories, namely, polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors; chemical, biochemical, biotechnological and bacteriological preparations for scientific purposes namely, bacteriological preparations producing polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors; diagnostic preparations for scientific purposes; proteins being raw materials
  • GS0051: Pharmaceutical, veterinary and sanitary products, namely, foods, dietetic beverages, and beverages for medical purposes, nutritional supplements for medical use, cultures and preparations of microorganisms for medical, pharmaceutical and veterinary purposes, bacteriological preparations for medical, pharmaceutical and veterinary purposes, medicines for veterinary purposes derived from or validated with stem-cell derived biologicals and for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, medicines for human purposes derived from or validated with stem-cell derived biologicals and for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, biological preparations for medical, pharmaceutical and veterinary purposes for grafts, cell therapy and regenerative medicine, for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, chemical and biochemical preparations for medical, pharmaceutical and veterinary purposes for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, chemical-pharmaceutical preparations for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, diagnostic preparations for medical purposes
  • GS0091: Scientific apparatus and instruments used in the implementation of biochemical analysis and molecular biology techniques, namely, automated biochemical analyzer, automated protein production and protein purification devices, biochemical, biological automated assay devices, nucleic acid break analyzer, devices for protein-nucleic acid interaction analysis; scientific apparatus and instruments for the mapping of all molecules' biological activities; data processing apparatus; multimedia products, namely, blank magnetic, blank optical, blank image and blank sound recording media; software for recording scientific and medical data on an on-line computer database in the field of pharmaceuticals and biotechnology, for simulation and design of biological and chemical products; apparatus and instruments for non-medical diagnosis, namely, computer hardware, microscopes, spectrometers
  • GS0421: Scientific research and industrial research in the field of genome engineering, protein engineering; scientific research in the field of genetics, medical, pharmaceutical and veterinary research; scientific research in the field of biology, biochemistry, molecular biology, bacteriology; scientific analysis; scientific research and development of biochemical, biological and molecular biology analysis techniques; research and development of new molecules for industrial use, scientific laboratory services, namely, isolation and preparation of stem cells; laboratory services, namely, imaging core lab services; engineering services, particularly technical project planning; computer programming, computer software and multimedia software design and development
  • GS0451: Intellectual property licensing; patent licensing
Case File Event Statements
  • 4/17/2020 - 5 years ago
    32 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED Type: DENC
  • 4/17/2020 - 5 years ago
    31 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH
  • 5/2/2019 - 6 years ago
    30 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 9/14/2018 - 7 years ago
    29 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT
  • 7/19/2018 - 7 years ago
    28 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS
  • 7/19/2018 - 7 years ago
    27 - INVALIDATION PROCESSED Type: INPC
  • 7/10/2018 - 7 years ago
    26 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR
  • 11/10/2017 - 7 years ago
    25 - CANCELLED SECTION 71 Type: C71T
  • 3/27/2014 - 11 years ago
    24 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 5/19/2013 - 12 years ago
    23 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 2/28/2013 - 12 years ago
    22 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 8/29/2011 - 14 years ago
    21 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 8/29/2011 - 14 years ago
    20 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 7/5/2011 - 14 years ago
    19 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 4/5/2011 - 14 years ago
    18 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 1/18/2011 - 14 years ago
    17 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/29/2010 - 14 years ago
    16 - NOTICE OF PUBLICATION Type: NPUB
  • 12/13/2010 - 14 years ago
    15 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 12/13/2010 - 14 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/19/2010 - 14 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/19/2010 - 14 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/19/2010 - 14 years ago
    11 - ASSIGNED TO LIE Type: ALIE
  • 11/4/2010 - 15 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/18/2010 - 15 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 5/7/2010 - 15 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 5/7/2010 - 15 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 5/5/2010 - 15 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 5/4/2010 - 15 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/27/2010 - 15 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 4/23/2010 - 15 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/23/2010 - 15 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 4/22/2010 - 15 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR